Literature DB >> 24144134

Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo.

Yobi Doudou1, Piarroux Renaud, L'Ollivier Coralie, Franck Jacqueline, Situakibanza Hypolite, Muhindo Hypolite, Mitashi Patrick, Inocêncio da Luz Raquel Andreia, Marc Van Sprundel, Boelaert Marleen, Jean-Pierre Van Geertruyden, Lutumba Pascal.   

Abstract

OBJECTIVE: To determine the seroprevalence of toxoplasmosis in pregnant women, as well as the proportion of acutely infected and risk factors in the Democratic Republic of Congo.
METHODS: Thirty maternities in Kinshasa were randomly selected and women attending antenatal consultation were invited to participate. They were interviewed with a structured questionnaire about known risk factors (age, meat consumption, contact with soil, and presence of cat) and a venous blood sample was taken. Sera were analysed for total immunoglobulins (Ig) by VIDAS Toxo Competition using Enzyme Linked Fluorescent Assay. IgM was determined by VIDIA Toxo IgM and IgG avidity by VIDAS Toxo IgG avidity.
RESULTS: A total of 781 women were included. Median age was 28 years old (IQR: 8.5). And 627 women (80.3%; 95% CI: 77.5-83.1) were found to be positive to total Ig and 17 out of 387 (4.4%; 95% CI: 2.3-6.4) were positive to IgM. IgG avidity was low for 2 (11.8%) women, intermediate for 2 (11.8%) and high for 13 women (76.4%). There was no statistically significant association between Toxoplasma gondii infection and any risk factors assessed.
CONCLUSION: In Kinshasa, toxoplasmosis endemicity is highly prevalent. One woman out of twenty five had a recent toxoplasmosis infection and 20% were not protected against primo-infection, indicating a need for measures to prevent and control toxoplasmosis during pregnancy.
Copyright © 2014 Asian Pacific Tropical Biomedical Magazine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Kinshasa; Pregnant women; Seroprevalence; Toxoplasmosis

Mesh:

Substances:

Year:  2014        PMID: 24144134      PMCID: PMC3819499          DOI: 10.1016/S2221-1691(14)60211-2

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  27 in total

1.  The placenta: a main role in congenital toxoplasmosis?

Authors:  Florence Robert-Gangneux; Jean-Benjamin Murat; Hélène Fricker-Hidalgo; Marie-Pierre Brenier-Pinchart; Jean-Pierre Gangneux; Hervé Pelloux
Journal:  Trends Parasitol       Date:  2011-11-11

2.  Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and Principe.

Authors:  Chien-Ching Hung; Chia-Kwung Fan; Kua-Eyre Su; Fung-Chang Sung; Hung-Yi Chiou; Vilfrido Gil; Maria da Conceicao dos Reis Ferreira; Jose Manuel de Carvalho; Claudina Cruz; Yu-Kuan Lin; Lian-Fen Tseng; Ke-Yun Sao; Wen-Cheun Chang; Hung-Shue Lan; Shing-Hsien Chou
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-11-17       Impact factor: 2.184

3.  Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.

Authors:  M H Bessières; A Berrebi; S Cassaing; J Fillaux; J P Cambus; A Berry; C Assouline; J M Ayoubi; J F Magnaval
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

4.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

5.  Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain.

Authors:  José M Ramos; Afredo Milla; Juan C Rodríguez; Sergio Padilla; Mar Masiá; Félix Gutiérrez
Journal:  Parasitol Res       Date:  2011-05-04       Impact factor: 2.289

6.  [Seroprevalence of toxoplasmosis in pregnant women in Rabat, Morocco].

Authors:  B El Mansouri; M Rhajaoui; F Sebti; F Amarir; M Laboudi; R Bchitou; M Hamad; M Lyagoubi
Journal:  Bull Soc Pathol Exot       Date:  2007-10

7.  [Serological study on toxoplasmosis among pregnant women from Franceville, Gabon].

Authors:  R Mpiga Mickoto; J-P Akue; U Bisvigou; S Mayi Tsonga; D Nkoghe
Journal:  Bull Soc Pathol Exot       Date:  2010-02

8.  [Prevention of congenital toxoplasmosis in a Buenos Aires hospital].

Authors:  Liliana Carral; Federico Kaufer; Patricia Olejnik; Cristina Freuler; Ricardo Durlach
Journal:  Medicina (B Aires)       Date:  2013       Impact factor: 0.653

9.  Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.

Authors:  M Wallon; F Peyron; C Cornu; S Vinault; M Abrahamowicz; C Bonithon Kopp; C Binquet
Journal:  Clin Infect Dis       Date:  2013-01-29       Impact factor: 9.079

10.  Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.

Authors:  Fisseha Walle; Nigatu Kebede; Aster Tsegaye; Tesfu Kassa
Journal:  Parasit Vectors       Date:  2013-01-16       Impact factor: 3.876

View more
  15 in total

1.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

2.  Seroprevalence of Toxoplasma gondii infection among pregnant women in Windhoek, Namibia, in 2016.

Authors:  Berta E van der Colf; Gert U van Zyl; Bruce H Noden; Dismas Ntirampeba
Journal:  S Afr J Infect Dis       Date:  2020-05-13

3.  Toxoplasmosis awareness, seroprevalence and risk behavior among pregnant women in the Gampaha district, Sri Lanka.

Authors:  Nilmini Chandrasena; Rasika Herath; Nawamalika Rupasinghe; Buddhini Samarasinghe; Hasaranga Samaranayake; Anuradhani Kastuririratne; Nilanthi Renuka de Silva
Journal:  Pathog Glob Health       Date:  2016-04-19       Impact factor: 2.894

4.  Association between seroprevalence of IgG anti-Toxoplasma gondii and risk factors for infection among pregnant women in Climério de Oliveira Maternity, Salvador, Bahia, Brazil.

Authors:  Maria Virginia Avelar; Victor Otero Martinez; Daniel Lima de Moura; Indira Alves Barros; Anderson Alves da Silva Primo; Alan Oliveira Duarte; Neci Matos Soares; Fernanda Washington de Mendonça Lima
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-12-21       Impact factor: 1.846

5.  Toxoplasma gondii seroprevalence among pregnant women attending antenatal clinic in Northern Tanzania.

Authors:  Eliakimu Paul; Ireen Kiwelu; Blandina Mmbaga; Rebeka Nazareth; Elias Sabuni; Athanasia Maro; Arnold Ndaro; Jo E B Halliday; Jaffu Chilongola
Journal:  Trop Med Health       Date:  2018-11-19

6.  Evaluation of the level of awareness of congenital toxoplasmosis and associated practices among pregnant women and health workers in Tanzania's Temeke district in Dar es Salaam.

Authors:  Onduru Gervas Onduru; Susan Fred Rumisha; Musso Munyeme; Andrew Malata Phiri
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

7.  The Seroprevalence and Risk Factors of Toxoplasmosis Among Female Undergraduate University Students in Saudi Arabia.

Authors:  Riyadh A Alzaheb; Osama Al-Amer
Journal:  Oman Med J       Date:  2017-11

8.  Toxoplasmosis infection among pregnant women in Africa: A systematic review and meta-analysis.

Authors:  Tamirat Tesfaye Dasa; Teshome Gensa Geta; Ayalnesh Zemene Yalew; Rahel Mezemir Abebe; Henna Umer Kele
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

9.  Toxoplasma infection in pregnant women: a current status in Songklanagarind hospital, southern Thailand.

Authors:  Hemah Andiappan; Veeranoot Nissapatorn; Nongyao Sawangjaroen; Waenurama Chemoh; Yee Ling Lau; Thulasi Kumar; Subashini Onichandran; Chitkasaem Suwanrath; Verapol Chandeying
Journal:  Parasit Vectors       Date:  2014-05-22       Impact factor: 3.876

10.  Knowledge and practice on Toxoplasma infection in pregnant women from Malaysia, Philippines, and Thailand.

Authors:  Hemah Andiappan; Veeranoot Nissapatorn; Nongyao Sawangjaroen; Si-Lay Khaing; Cristina C Salibay; Mary Mae M Cheung; Julieta Z Dungca; Waenurama Chemoh; Ching Xiao Teng; Yee-Ling Lau; Noor A Mat Adenan
Journal:  Front Microbiol       Date:  2014-06-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.